Elmar Kraus
Stock Analyst at DZ BANK AG
(4.05)
# 1,603
Out of 4,345 analysts
145
Total ratings
70.8%
Success rate
10.2%
Average return
Main Sectors:
Stocks Rated by Elmar Kraus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0QW0 argenx SE | Maintained: Buy | n/a | $710.90 | - | 2 | May 8, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | n/a | $288.35 | - | 13 | May 7, 2026 | |
| PFE Pfizer | Maintained: Buy | n/a | $26.21 | - | 9 | May 6, 2026 | |
| LON: AZN AstraZeneca PLC | Upgraded: Buy | 16,400p | $14,008.00 | +17.08% | 13 | Apr 29, 2026 | |
| LON: GSK GSK plc | Maintained: Hold | n/a | $1,939.50 | - | 9 | Apr 29, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | n/a | $119.58 | - | 8 | Apr 28, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Buy | n/a | $330.90 | - | 12 | Feb 2, 2026 | |
| ABBV AbbVie | Downgraded: Hold | $188 → $237 | $215.40 | +10.03% | 4 | Nov 4, 2025 | |
| EPA: SAN Sanofi | Maintained: Buy | n/a | $77.14 | - | 9 | Oct 24, 2025 | |
| AMS: PHIA Koninklijke Philips N.V. | Maintained: Hold | n/a | $22.97 | - | 7 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $72 → $108 | $133.69 | n/a | 7 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $331 → $343 | $336.06 | n/a | 5 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,068 → $1,065 | $627.74 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $820 → $800 | $1,082.92 | n/a | 6 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $50 | $57.52 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $148 | $120.24 | n/a | 2 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $181 → $176 | $231.29 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $242 → $236 | $196.97 | n/a | 4 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $22.17 | n/a | 1 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $35.08 | n/a | 20 | Apr 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $51.58 | n/a | 1 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $38.44 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $92 | $75.98 | n/a | 2 | May 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $42 | $26.60 | n/a | 1 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $44.55 | n/a | 1 | May 3, 2018 |
argenx SE
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $710.90
Upside: -
Novo Nordisk A/S
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $288.35
Upside: -
Pfizer
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $26.21
Upside: -
AstraZeneca PLC
Apr 29, 2026
Upgraded: Buy
Price Target: 16,400p
Current: $14,008.00
Upside: +17.08%
GSK plc
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $1,939.50
Upside: -
Novartis AG
Apr 28, 2026
Maintained: Hold
Price Target: n/a
Current: $119.58
Upside: -
Roche Holding AG
Feb 2, 2026
Maintained: Buy
Price Target: n/a
Current: $330.90
Upside: -
AbbVie
Nov 4, 2025
Downgraded: Hold
Price Target: $188 → $237
Current: $215.40
Upside: +10.03%
Sanofi
Oct 24, 2025
Maintained: Buy
Price Target: n/a
Current: $77.14
Upside: -
Koninklijke Philips N.V.
Jul 29, 2025
Maintained: Hold
Price Target: n/a
Current: $22.97
Upside: -
Feb 13, 2025
Upgraded: Buy
Price Target: $72 → $108
Current: $133.69
Upside: n/a
May 7, 2024
Maintained: Buy
Price Target: $331 → $343
Current: $336.06
Upside: n/a
May 6, 2024
Maintained: Buy
Price Target: $1,068 → $1,065
Current: $627.74
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $820 → $800
Current: $1,082.92
Upside: n/a
Apr 30, 2024
Maintained: Buy
Price Target: $61 → $50
Current: $57.52
Upside: n/a
Apr 29, 2024
Maintained: Buy
Price Target: $125 → $148
Current: $120.24
Upside: n/a
Apr 18, 2024
Maintained: Buy
Price Target: $181 → $176
Current: $231.29
Upside: n/a
Feb 15, 2024
Maintained: Hold
Price Target: $242 → $236
Current: $196.97
Upside: n/a
Nov 2, 2023
Maintained: Buy
Price Target: $39
Current: $22.17
Upside: n/a
Apr 20, 2022
Maintained: Hold
Price Target: n/a
Current: $35.08
Upside: n/a
Feb 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $51.58
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: n/a
Current: $38.44
Upside: n/a
May 14, 2020
Downgraded: Hold
Price Target: $90 → $92
Current: $75.98
Upside: n/a
Mar 24, 2020
Upgraded: Buy
Price Target: $42
Current: $26.60
Upside: n/a
May 3, 2018
Maintained: Sell
Price Target: n/a
Current: $44.55
Upside: n/a